Skip to content

Unilife Medical Solutions

Investor Relations


Unilife is a U.S. based medical device company focused on the design, development, manufacture and supply of a proprietary range of retractable syringes. Primary target customers for our products include pharmaceutical manufacturers, suppliers of medical equipment to healthcare facilities and patients who self-administer prescription medication. All of our syringes incorporate automatic and fully-integrated safety features which are designed to protect those at risk of needlestick injuries and unsafe injection practices. We are ISO 13485 certified and have FDA-registered medical device manufacturing facilities in Pennsylvania.

Read More »

Recent Releases

Nov 29, 2011
Unilife Signs Clinical Development and Supply Agreement with Global Pharmaceutical Company

Nov 21, 2011
Unilife Corporation Announces Completion of Offering of 8,250,000 Shares of Common Stock

View all releases »

Financial Information
Financial Summary
SEC Filings
Annual Reports
Quarterly Results
Key Ratios
Stock Information
Stock Performance
Historic Stock Lookup
Investment Calculator
Analyst Coverage
ASX Stock Data
News and Events
Press Releases
Events
Presentations
Corporate Governance
Introduction
Management
Board of Directors
Committee Composition
Policies and Guidelines
Ethics Hotline
Contact the Board
Investor Facts
Trading on Unilife FAQ
Tax Ruling
Contact Us
Contact Us


NASDAQ:UNIS
Date  Jan 27, 2012
Time  3:59 PM ET
Last Price  $4.23
Change  + 0.08 0.08 (1.928%)
Quotes delayed at least 20 minutes.
Information provided by eSignal.